Durability of Results: Maintenance Studies: Tirzepatide (SURMOUNT-3): Continued treatment: Additional 5.5% weight loss Stopped treatment: Regained 14% of weight Conclusion: Need ongoing treatment Semaglutide (STEP-4): Continued treatment: Maintained loss, continued losing Stopped treatment: Regained most weight Conclusion: Need ongoing treatment Phentermine: FDA-approved for 12 weeks only Weight regain after stopping is universal Not a long-term solution All Weight Loss Medications: Obesity is chronic disease Medications treat symptoms, dont cure Stopping medication weight regain Long-term or indefinite use necessary for sustained results Safety Profile Comparison: Discontinuation Due to Side Effects: Tirzepatide: 6.2% Semaglutide: 6.9% Liraglutide: 9.9% Naltrexone-bupropion: 25% (very high) Orlistat: 15-20% Phentermine-topiramate: 8-10% GLP-1s have excellent tolerability considering their effectiveness
It can help create a calorie deficit
That binding produces three clinically measurable effects: Satiety: patients describe getting full earlier and staying full longer, which reduces intake without the need for calorie counting
If you feel worse when you skip food, read signs you may be eating too little on Ozempic
Whatever the exact mechanism may be, its likely the drugs pack a one-two punch, working both on the tumor cells themselves, as well as their environment, he added
Americas healthcare system stands at a remarkable crossroads
